Cargando…
Sequential P‐GEMOX and radiotherapy for early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study
Extranodal natural killer/T‐cell lymphoma, nasal‐type (ENKTL) is a distinct subtype of non‐Hodgkin lymphoma and most of the patients presented localized disease. Combined modality therapy (CMT), namely chemotherapy combined with radiotherapy, has been recommended for patients with early‐stage ENKTL....
Autores principales: | Zhang, Yuchen, Ma, Shuyun, Cai, Jun, Yang, Yu, Jing, Hongmei, Shuang, Yuerong, Peng, Zhigang, Li, Bingzong, Liu, Panpan, Xia, Zhongjun, Xia, Yi, Gao, Yan, Chen, Daoguang, Lin, Jianyang, Li, Qihui, Xu, Shenghua, Xu, Qingyuan, Zhang, Han, Huang, Huiqiang, Cai, Qingqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291061/ https://www.ncbi.nlm.nih.gov/pubmed/34449095 http://dx.doi.org/10.1002/ajh.26335 |
Ejemplares similares
-
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma
por: Cai, Jun, et al.
Publicado: (2020) -
Association between extranodal natural killer/T-cell lymphoma and hepatitis B viral infection: a case-control study
por: Wang, Kefeng, et al.
Publicado: (2017) -
Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
por: Wang, Hua, et al.
Publicado: (2016) -
P1131: SERUM TRIGLYCERIDE AND APOLIPOPROTEIN A1 AS BIOMARKERS FOR EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA (ENKTL): A MULTICENTER STUDY
por: Cai, Qingqing, et al.
Publicado: (2023) -
Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study
por: Wei, Liqiang, et al.
Publicado: (2020)